Collectively these results proposed a model in which JNJ treatment increases the histone acetylation at the promoter region of CEBPA gene, resulting in the recruitment of BRD4 for the restoration of CEBPA expression in the LMP1-expressing NPC-derived cells. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.